MYELODYSPLASTIC SYNDROMES: DIAGNOSIS AND RISK STRATIFICATION-ENDURING

Once monthly 1 CME credit hour events directed toward advanced practice providers as well as pharmacists and registered nurses who care for all patients treated at Duke Cancer Institute.

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physician Assistants
  • Pharmacists

Learning Objectives

  • Understanding the definition of MDS
  • Understanding morphologic evidence of MDS
  • Understanding classification and risk stratification of MDS
Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
02/15/2024
Registration Expires: 
02/14/2026
Part of: 
DCI-ADVANCED PRACTICE PROVIDER LECTURE SERIES 2024-ENDURING
Rating: 
0
Durham, NC 27705
United States
  • Harry Erba, MD, PhD
  • ACPE - Pharmacist
  • AMA PRA Category 1 Credit(s)
  • ANCC
  • Attendance
  • JA Credit - AH

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.